SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : Value Investing -- Ignore unavailable to you. Want to Upgrade?

To: Paul Senior who wrote (16812)4/10/2003 4:49:09 PM
From: Larry S.  Read Replies (1) | Respond to of 78654
 
I'm tempted to enter a position in BMY - Bristol Myers. Granted the news has been dismal, but all that is well reflected in the stock price. the dividend is generous, and there's the hint of a takeover at this low price, though the market cap is still hefty at 43 billion. thoughts appreciated. larry



To: Paul Senior who wrote (16812)4/12/2003 1:28:54 PM
From: Spekulatius  Read Replies (1) | Respond to of 78654
 
AZ -Issuance of large amounts of rights will keep pressure on the stock. (imo). Avoid. (imo). Agreed unfortunately :-).
The huge right issue is an embarassement, especially since they refused to sell their very valuable Beiersdorf stake very recently. Also the deeply discounted right's will not be offered to AZ ADR's holders, which is even more embarassing to foreign investors.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News